{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T17:00:49Z","timestamp":1780160449568,"version":"3.54.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["DARU J Pharm Sci"],"DOI":"10.1007\/s40199-026-00598-x","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T14:54:05Z","timestamp":1773759245000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Network analysis-guided drug repurposing: IGF1R as a novel melanoma target and therapeutic potential of dapagliflozin"],"prefix":"10.1007","volume":"34","author":[{"given":"Fatemeh","family":"Hajipour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melika","family":"Alesheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maliheh","family":"Safavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Safari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid Tavakkol","family":"Hamedani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loghman","family":"Firoozpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"598_CR1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(18)31559-9","volume":"392","author":"D Schadendorf","year":"2018","unstructured":"Schadendorf D, van Akkooi ACJ, Berking C, Griewank KG, Gutzmer R, Hauschild A, et al. Melanoma. Lancet. 2018;392:971\u201384. https:\/\/doi.org\/10.1016\/S0140-6736(18)31559-9.","journal-title":"Lancet"},{"key":"598_CR2","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1038\/s41467-020-16653-6]","volume":"11","author":"VW Rebecca","year":"2020","unstructured":"Rebecca VW, Somasundaram R, Herlyn M. Pre-clinical modeling of cutaneous melanoma. Nat Commun. 2020;11:2858. https:\/\/doi.org\/10.1038\/s41467-020-16653-6].","journal-title":"Nat Commun"},{"key":"598_CR3","first-page":"367","volume":"110","author":"R Lauters","year":"2024","unstructured":"Lauters R, Brown AD, Harrington KA, Melanoma. Diagnosis and Treatment. Am Fam Physician. 2024;110:367\u201377.","journal-title":"Am Fam Physician"},{"key":"598_CR4","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrclinonc.2017.43","volume":"14","author":"JJ Luke","year":"2017","unstructured":"Luke JJ, Flaherty KT, Ribas A, Long GV. Targeted agents and immunotherapies: optimizing outcomes in melanoma. Nat Rev Clin Oncol. 2017;14:463\u201382. https:\/\/doi.org\/10.1038\/nrclinonc.2017.43.","journal-title":"Nat Rev Clin Oncol"},{"key":"598_CR5","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1080\/15384047.2019.1680538]","volume":"20","author":"LE Davis","year":"2019","unstructured":"Davis LE, Shalin SC, Tackett AJ. Current state of melanoma diagnosis and treatment. Cancer Biol Ther. 2019;20:1366\u201379. https:\/\/doi.org\/10.1080\/15384047.2019.1680538].","journal-title":"Cancer Biol Ther"},{"key":"598_CR6","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S0140-6736(21)01204-4]","volume":"398","author":"MS Carlino","year":"2021","unstructured":"Carlino MS, Larkin J, Long GV. Immune checkpoint inhibitors in melanoma. Lancet. 2021;398:1002\u201314. https:\/\/doi.org\/10.1016\/S0140-6736(21)01204-4].","journal-title":"Lancet"},{"key":"598_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"598_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17\u201348. https:\/\/doi.org\/10.3322\/caac.21763.","journal-title":"CA Cancer J Clin"},{"key":"598_CR9","doi-asserted-by":"publisher","unstructured":"Marchetti MA, Codella NCF, Dusza SW, Gutman DA, Helba B, Kalloo A, Mishra N, Carrera C, Celebi ME, DeFazio JL et al. Results of the 2016 International Skin Imaging Collaboration International Symposium on Biomedical Imaging challenge: Comparison of the accuracy of computer algorithms to dermatologists for the diagnosis of melanoma from dermoscopic images. J Am Acad Dermatol\u00a02018;78, 270\u2013277.e1. [https:\/\/doi.org\/10.1016\/j.jaad.2017.08.028]","DOI":"10.1016\/j.jaad.2017.08.028]"},{"key":"598_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1056\/NEJMoa1412690","volume":"372","author":"C Robert","year":"2015","unstructured":"Robert C, Karaszewska B, Schachter J, Rutkowski P, Mackiewicz A, Stroiakovski D, et al. Improved overall survival in melanoma with combined dabrafenib and trametinib. N Engl J Med. 2015;372:30\u20139. https:\/\/doi.org\/10.1056\/NEJMoa1412690.","journal-title":"N Engl J Med"},{"key":"598_CR11","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/S0140-6736(15)60898-4]","volume":"386","author":"GV Long","year":"2015","unstructured":"Long GV, Stroyakovskiy D, Gogas H, Levchenko E, de Braud F, Larkin J, Chiarion-Sileni V, Kefford R, Kirkwood JM, Wolter P, et al. Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial. Lancet. 2015;386:444\u201351. https:\/\/doi.org\/10.1016\/S0140-6736(15)60898-4].","journal-title":"Lancet"},{"key":"598_CR12","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1200\/JCO.21.02485]","volume":"40","author":"R Dummer","year":"2022","unstructured":"Dummer R, Nathan P, Ascierto PA, Gogas HJ, Chiarion-Sileni V, Mandala M, Lesimple T, Lebb\u00e9 C, Nyakas M, Rozeman EA, et al. Randomized Phase III Trial Evaluating Spartalizumab Plus Dabrafenib and Trametinib for BRAF V600-Mutant Unresectable or Metastatic Melanoma. J Clin Oncol. 2022;40:1428\u201338. https:\/\/doi.org\/10.1200\/JCO.21.02485].","journal-title":"J Clin Oncol"},{"key":"598_CR13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ejca.2017.07.028]","volume":"83","author":"S Ugurel","year":"2017","unstructured":"Ugurel S, R\u00f6hmel J, Ascierto PA, Flaherty KT, Gogas HJ, Grob J-J, Hauschild A, Larkin J, Long GV, Lorigan P, et al. Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017. Eur J Cancer. 2017;83:247\u201357. https:\/\/doi.org\/10.1016\/j.ejca.2017.07.028].","journal-title":"Eur J Cancer"},{"key":"598_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s43094-024-00112-y","volume":"10","author":"M Nasim","year":"2024","unstructured":"Nasim M, Farhat G, Hussain I, Farooq U, Shahzad A, Younis H, et al. Novel paradigm of therapeutic intervention for skin cancer: challenges and opportunities. Future J Pharm Sci. 2024;10:112. https:\/\/doi.org\/10.1186\/s43094-024-00112-y.","journal-title":"Future J Pharm Sci"},{"key":"598_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16010001","volume":"16","author":"V Costa","year":"2023","unstructured":"Costa V, Giovannetti E, Lonardo E. Revolutionizing cancer treatment: unveiling new frontiers by targeting the (Un)Usual suspects. Cancers (Basel). 2023;16:23. https:\/\/doi.org\/10.3390\/cancers16010001.","journal-title":"Cancers (Basel)"},{"key":"598_CR16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.aad0501","volume":"352","author":"I Tirosh","year":"2016","unstructured":"Tirosh I, Izar B, Prakadan SM, Wadsworth MH, Treacy D, Trombetta JJ, et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science. 2016;352:189\u201396. https:\/\/doi.org\/10.1126\/science.aad0501.","journal-title":"Science"},{"key":"598_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2024.101255","volume":"96","author":"CU Yuan","year":"2024","unstructured":"Yuan CU, Quah FX, Hemberg M. Single-cell and spatial transcriptomics: bridging current technologies with long-read sequencing. Mol Aspects Med. 2024;96:101255. https:\/\/doi.org\/10.1016\/j.mam.2024.101255.","journal-title":"Mol Aspects Med"},{"key":"598_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30002-7","volume":"17","author":"TK Burki","year":"2016","unstructured":"Burki TK. Defining the genetics of melanoma progression. Lancet Oncol. 2016;17:e7. https:\/\/doi.org\/10.1016\/S1470-2045(16)30002-7.","journal-title":"Lancet Oncol"},{"key":"598_CR19","doi-asserted-by":"publisher","DOI":"10.1098\/rsif.2017.0387","volume":"15","author":"T Ching","year":"2018","unstructured":"Ching T, Himmelstein DS, Beaulieu-Jones BK, Kalinin AA, Do BT, Way GP, et al. Opportunities and obstacles for deep learning in biology and medicine. J R Soc Interface. 2018;15:20170387. https:\/\/doi.org\/10.1098\/rsif.2017.0387.","journal-title":"J R Soc Interface"},{"key":"598_CR20","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044]","volume":"161","author":"The Cancer Genome Atlas Network","year":"2015","unstructured":"The Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015;161:1681\u201396. https:\/\/doi.org\/10.1016\/j.cell.2015.05.044].","journal-title":"Cell"},{"key":"598_CR21","doi-asserted-by":"publisher","first-page":"100139","DOI":"10.1016\/j.xcrm.2020.100139]","volume":"1","author":"V Anagnostou","year":"2020","unstructured":"Anagnostou V, Smith KN, Forde PM, Niknafs N, Bhattacharya R, White J, Zhang T, Adleff V, Phallen J, Wali N, et al. Integrative Tumor and Immune Cell Multi-omic Analyses Predict Response to Immune Checkpoint Blockade in Melanoma. Cell Rep Med. 2020;1:100139. https:\/\/doi.org\/10.1016\/j.xcrm.2020.100139].","journal-title":"Cell Rep Med"},{"key":"598_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s41065-025-00238-y","volume":"162","author":"F Shen","year":"2025","unstructured":"Shen F, Zhu S, Feng J, Wang C, Zhu X. Integrative bioinformatics analysis of high-throughput sequencing and in vitro functional analysis leads to uncovering key hub genes in esophageal squamous cell carcinoma. Hereditas. 2025;162:38. https:\/\/doi.org\/10.1186\/s41065-025-00238-y.","journal-title":"Hereditas"},{"key":"598_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/jpm8030029","volume":"8","author":"M Morash","year":"2018","unstructured":"Morash M, Mitchell H, Beltran H, Elemento O, Pathak J. The role of next-generation sequencing in precision medicine: a review of outcomes in oncology. J Pers Med. 2018;8:25. https:\/\/doi.org\/10.3390\/jpm8030029.","journal-title":"J Pers Med"},{"key":"598_CR24","doi-asserted-by":"publisher","first-page":"371","DOI":"10.4103\/jomfp.jomfp_371_20","volume":"25","author":"M Sahu","year":"2021","unstructured":"Sahu M, Suryawanshi H. Immunotherapy: the future of cancer treatment. J Oral Maxillofac Pathol. 2021;25:371. https:\/\/doi.org\/10.4103\/jomfp.jomfp_371_20.","journal-title":"J Oral Maxillofac Pathol"},{"key":"598_CR25","doi-asserted-by":"publisher","first-page":"D760","DOI":"10.1093\/nar\/gkl887","volume":"35","author":"T Barrett","year":"2007","unstructured":"Barrett T, Troup DB, Wilhite SE, Ledoux P, Rudnev D, Evangelista C, et al. NCBI GEO: mining tens of millions of expression profiles\u2013database and tools update. Nucleic Acids Res. 2007;35:D760\u20135. https:\/\/doi.org\/10.1093\/nar\/gkl887.","journal-title":"Nucleic Acids Res"},{"key":"598_CR26","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","volume":"30","author":"R Edgar","year":"2002","unstructured":"Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30:207\u201310. https:\/\/doi.org\/10.1093\/nar\/30.1.207.","journal-title":"Nucleic Acids Res"},{"key":"598_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47. https:\/\/doi.org\/10.1093\/nar\/gkv007.","journal-title":"Nucleic Acids Res"},{"key":"598_CR28","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","volume":"20","author":"L Gautier","year":"2004","unstructured":"Gautier L, Cope L, Bolstad BM, Irizarry RA. Affy\u2013analysis of Affymetrix GeneChip data at the probe level. Bioinformatics. 2004;20:307\u201315. https:\/\/doi.org\/10.1093\/bioinformatics\/btg405.","journal-title":"Bioinformatics"},{"key":"598_CR29","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ygeno.2010.01.003","volume":"95","author":"A Kauffmann","year":"2010","unstructured":"Kauffmann A, Huber W. Microarray data quality control improves the detection of differentially expressed genes. Genomics. 2010;95:138\u201342. https:\/\/doi.org\/10.1016\/j.ygeno.2010.01.003.","journal-title":"Genomics"},{"key":"598_CR30","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","volume":"4","author":"RA Irizarry","year":"2003","unstructured":"Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4:249\u201364. https:\/\/doi.org\/10.1093\/biostatistics\/4.2.249.","journal-title":"Biostatistics"},{"key":"598_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000;25:25\u20139. https:\/\/doi.org\/10.1038\/75556.","journal-title":"Nat Genet"},{"key":"598_CR32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27]","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27].","journal-title":"Nucleic Acids Res"},{"key":"598_CR33","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51:D638\u201346. https:\/\/doi.org\/10.1093\/nar\/gkac1000.","journal-title":"Nucleic Acids Res"},{"key":"598_CR34","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498\u2013504. https:\/\/doi.org\/10.1101\/gr.1239303.","journal-title":"Genome Res"},{"key":"598_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1758-4","volume":"20","author":"D Otasek","year":"2019","unstructured":"Otasek D, Morris JH, Bou\u00e7as J, Pico AR, Demchak B. Cytoscape automation: empowering workflow-based network analysis. Genome Biol. 2019;20:185. https:\/\/doi.org\/10.1186\/s13059-019-1758-4.","journal-title":"Genome Biol"},{"key":"598_CR36","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545\u201350. https:\/\/doi.org\/10.1073\/pnas.0506580102.","journal-title":"Proc Natl Acad Sci USA"},{"key":"598_CR37","doi-asserted-by":"crossref","unstructured":"Bastian M, Heymann S, Jacomy M, Gephi. An Open Source Software for Exploring and Manipulating Networks. In Proceedings of the International AAAI Conference on Web and Social Media, San Jose, CA, USA, 17\u201320 2009; pp. 361\u2013362.","DOI":"10.1609\/icwsm.v3i1.13937"},{"key":"598_CR38","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/spe.4380211102","volume":"21","author":"TMJ Fruchterman","year":"1991","unstructured":"Fruchterman TMJ, Reingold EM. Graph drawing by force-directed placement. Softw Pract Exp. 1991;21:1129\u201364. https:\/\/doi.org\/10.1002\/spe.4380211102.","journal-title":"Softw Pract Exp"},{"key":"598_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics. 2013;14:128. https:\/\/doi.org\/10.1186\/1471-2105-14-128.","journal-title":"BMC Bioinformatics"},{"key":"598_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.90","volume":"1","author":"Z Xie","year":"2021","unstructured":"Xie Z, Bailey A, Kuleshov MV, Clarke DJB, Evangelista JE, Jenkins SL, et al. Gene set knowledge discovery with Enrichr. Curr Protoc. 2021;1:e90. https:\/\/doi.org\/10.1002\/cpz1.90.","journal-title":"Curr Protoc"},{"key":"598_CR41","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1385\/1-59259-584-7:531]","volume":"112","author":"MR Wilkins","year":"1999","unstructured":"Wilkins MR, Gasteiger E, Bairoch A, Sanchez JC, Williams KL, Appel RD, Hochstrasser DF. Protein identification and analysis tools in the ExPASy server. Methods Mol Biol. 1999;112:531\u201352. https:\/\/doi.org\/10.1385\/1-59259-584-7:531].","journal-title":"Methods Mol Biol"},{"key":"598_CR42","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235]","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. The Protein Data Bank. Nucleic Acids Res. 2000;28:235\u201342. https:\/\/doi.org\/10.1093\/nar\/28.1.235].","journal-title":"Nucleic Acids Res"},{"key":"598_CR43","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem. 2009;30:2785\u201391. https:\/\/doi.org\/10.1002\/jcc.21256.","journal-title":"J Comput Chem"},{"key":"598_CR44","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037]","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Saye-Mecerdor G, et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018;46:D1074\u201382. https:\/\/doi.org\/10.1093\/nar\/gkx1037].","journal-title":"Nucleic Acids Res"},{"key":"598_CR45","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1021\/ci200227u","volume":"51","author":"RA Laskowski","year":"2011","unstructured":"Laskowski RA, Swindells MB. LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model. 2011;51:2778\u201386. https:\/\/doi.org\/10.1021\/ci200227u.","journal-title":"J Chem Inf Model"},{"key":"598_CR46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1\u20132","author":"MJ Abraham","year":"2015","unstructured":"Abraham MJ, Murtola T, Schulz R, P\u00e1ll S, Smith JC, Hess B, Lindahl E. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015;1\u20132:19\u201325. https:\/\/doi.org\/10.1016\/j.softx.2015.06.001.","journal-title":"SoftwareX"},{"key":"598_CR47","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/jcc.21367","volume":"31","author":"K Vanommeslaeghe","year":"2010","unstructured":"Vanommeslaeghe K, Hatcher E, Acharya C, Kundu S, Zhong S, Shim J, et al. CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. J Comput Chem. 2010;31:671\u201390. https:\/\/doi.org\/10.1002\/jcc.21367.","journal-title":"J Comput Chem"},{"key":"598_CR48","doi-asserted-by":"publisher","unstructured":"MacKerell AD Jr., Bashford D, Bellott M, Dunbrack RL Jr., Evanseck JD, Field MJ, et al. All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B. 1998;102:3586\u2013616. https:\/\/doi.org\/10.1021\/jp973084f.","DOI":"10.1021\/jp973084f"},{"key":"598_CR49","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. Comparison of simple potential functions for simulating liquid water. J Chem Phys. 1983;79:926\u201335. https:\/\/doi.org\/10.1063\/1.445869.","journal-title":"J Chem Phys"},{"key":"598_CR50","doi-asserted-by":"publisher","DOI":"10.1063\/1.2408420","volume":"126","author":"G Bussi","year":"2007","unstructured":"Bussi G, Donadio D, Parrinello M. Canonical sampling through velocity rescaling. J Chem Phys. 2007;126:014101. https:\/\/doi.org\/10.1063\/1.2408420.","journal-title":"J Chem Phys"},{"key":"598_CR51","doi-asserted-by":"publisher","first-page":"7182","DOI":"10.1063\/1.328693","volume":"52","author":"M Parrinello","year":"1981","unstructured":"Parrinello M, Rahman A. Polymorphic transitions in single crystals: a new molecular dynamics method. J Appl Phys. 1981;52:7182\u201390. https:\/\/doi.org\/10.1063\/1.328693.","journal-title":"J Appl Phys"},{"key":"598_CR52","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","volume":"18","author":"B Hess","year":"1997","unstructured":"Hess B, Bekker H, Berendsen HJC, Fraaije JGEM. LINCS: a linear constraint solver for molecular simulations. J Comput Chem. 1997;18:1463\u201372. https:\/\/doi.org\/10.1002\/(SICI)1096-987X(199709)18:12.","journal-title":"J Comput Chem"},{"key":"598_CR53","doi-asserted-by":"publisher","first-page":"10089","DOI":"10.1063\/1.464397","volume":"98","author":"T Darden","year":"1993","unstructured":"Darden T, York D, Pedersen L. Particle mesh Ewald: an N\u22c5log(N) method for Ewald sums in large systems. J Chem Phys. 1993;98:10089\u201392. https:\/\/doi.org\/10.1063\/1.464397.","journal-title":"J Chem Phys"},{"key":"598_CR54","doi-asserted-by":"publisher","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","volume":"119","author":"E Wang","year":"2019","unstructured":"Wang E, Sun H, Wang J, Wang Z, Liu H, Zhang JZH, et al. End-point binding free energy calculation with MM\/PBSA and MM\/GBSA: strategies and applications in drug design. Chem Rev. 2019;119:9478\u2013508. https:\/\/doi.org\/10.1021\/acs.chemrev.9b00055.","journal-title":"Chem Rev"},{"key":"598_CR55","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1021\/ci100275a","volume":"51","author":"T Hou","year":"2011","unstructured":"Hou T, Wang J, Li Y, Wang W. Assessing the performance of the MM\/PBSA and MM\/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations. J Chem Inf Model. 2011;51:69\u201382. https:\/\/doi.org\/10.1021\/ci100275a.","journal-title":"J Chem Inf Model"},{"key":"598_CR56","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1146\/annurev-biophys-052118-115325","volume":"48","author":"AV Onufriev","year":"2019","unstructured":"Onufriev AV, Case DA. Generalized born implicit solvent models for biomolecules. Annu Rev Biophys. 2019;48:275\u201396. https:\/\/doi.org\/10.1146\/annurev-biophys-052118-115325.","journal-title":"Annu Rev Biophys"},{"key":"598_CR57","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/319199a0","volume":"319","author":"D Eisenberg","year":"1986","unstructured":"Eisenberg D, McLachlan AD. Solvation energy in protein folding and binding. Nature. 1986;319:199\u2013203. https:\/\/doi.org\/10.1038\/319199a0.","journal-title":"Nature"},{"key":"598_CR58","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1093\/bioinformatics\/18.12.1585","volume":"18","author":"E Hubbell","year":"2002","unstructured":"Hubbell E, Liu WM, Mei R. Robust estimators for expression analysis. Bioinformatics. 2002;18:1585\u201392. https:\/\/doi.org\/10.1093\/bioinformatics\/18.12.1585.","journal-title":"Bioinformatics"},{"key":"598_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0220061","volume":"14","author":"S Oldham","year":"2019","unstructured":"Oldham S, Fulcher B, Parkes L, Arnatkevi\u010di\u016bt\u0117 A, Suo C, Fornito A. Consistency and differences between centrality measures across distinct classes of networks. PLoS One. 2019;14:e0220061. https:\/\/doi.org\/10.1371\/journal.pone.0220061.","journal-title":"PLoS One"},{"key":"598_CR60","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa M, Sato Y, Kawashima M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 2023;51:D587\u201392. https:\/\/doi.org\/10.1093\/nar\/gkac963.","journal-title":"Nucleic Acids Res"},{"key":"598_CR61","doi-asserted-by":"publisher","first-page":"iyad031","DOI":"10.1093\/genetics\/iyad031]","volume":"224","author":"SA Aleksander","year":"2023","unstructured":"Aleksander SA, Balhoff J, Carbon S, Cherry JM, Drabkin HJ, Ebert D, Feuermann M, Gaudet P, Harris NL, Hill DP, et al. The Gene Ontology knowledgebase in 2023. Genetics. 2023;224:iyad031. https:\/\/doi.org\/10.1093\/genetics\/iyad031].","journal-title":"Genetics"},{"key":"598_CR62","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0022-2836(82)90515-0","volume":"157","author":"J Kyte","year":"1982","unstructured":"Kyte J, Doolittle RF. A simple method for displaying the hydropathic character of a protein. J Mol Biol. 1982;157:105\u201332. https:\/\/doi.org\/10.1016\/0022-2836(82)90515-0.","journal-title":"J Mol Biol"},{"key":"598_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1519345","volume":"15","author":"Q Li","year":"2024","unstructured":"Li Q, Li H. Integrating bioinformatics and machine learning to identify AhR-related gene signatures for prognosis and tumor microenvironment modulation in melanoma. Front Immunol. 2024;15:1519345. https:\/\/doi.org\/10.3389\/fimmu.2024.1519345.","journal-title":"Front Immunol"},{"key":"598_CR64","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.2967\/jnumed.123.456789","volume":"65","author":"SC Dougherty","year":"2024","unstructured":"Dougherty SC, Flowers WL, Gaughan EM. Precision oncology in melanoma: changing practices. J Nucl Med. 2024;65:1838. https:\/\/doi.org\/10.2967\/jnumed.123.456789.","journal-title":"J Nucl Med"},{"key":"598_CR65","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bmt.2023.04.002","volume":"4","author":"Y Ding","year":"2023","unstructured":"Ding Y, Liu C, He D, Wang Z, Li M, Yan J, et al. Overcoming melanoma resistance to immune checkpoint blockade therapy using nano-strategies. Biomed Tech (Berl). 2023;4:41\u20139. https:\/\/doi.org\/10.1016\/j.bmt.2023.04.002.","journal-title":"Biomed Tech (Berl)"},{"key":"598_CR66","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41422-020-0337-2","volume":"30","author":"YR Murciano-Goroff","year":"2020","unstructured":"Murciano-Goroff YR, Warner AB, Wolchok JD. The future of cancer immunotherapy: microenvironment-targeting combinations. Cell Res. 2020;30:507\u201319. https:\/\/doi.org\/10.1038\/s41422-020-0337-2.","journal-title":"Cell Res"},{"key":"598_CR67","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2009","unstructured":"Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44\u201357. https:\/\/doi.org\/10.1038\/nprot.2008.211.","journal-title":"Nat Protoc"},{"key":"598_CR68","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/bs.acr.2020.04.005]","volume-title":"Advances in Cancer Research","author":"LM Fettig","year":"2020","unstructured":"Fettig LM, Yee D. Advances in insulin-like growth factor biology and -directed cancer therapeutics. In: Kumar R, Fisher PB, editors. Advances in Cancer Research. 2nd ed. Cambridge, MA, USA: Academic; 2020. pp. 229\u201357. https:\/\/doi.org\/10.1016\/bs.acr.2020.04.005].","edition":"2"},{"key":"598_CR69","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.64.8.427","volume":"64","author":"C Chattopadhyay","year":"2023","unstructured":"Chattopadhyay C, Singh N, Singh AD. Targeting the IGF-1\/IGF-1R signaling in uveal melanoma inhibits cell survival, cell migration and reduces tumor growth. Invest Ophthalmol Vis Sci. 2023;64:427. https:\/\/doi.org\/10.1167\/iovs.64.8.427.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"598_CR70","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1038\/sj.bjc.6602627","volume":"92","author":"O Larsson","year":"2005","unstructured":"Larsson O, Girnita A, Girnita L. Role of insulin-like growth factor 1 receptor signalling in cancer. Br J Cancer. 2005;92:2097\u2013101. https:\/\/doi.org\/10.1038\/sj.bjc.6602627.","journal-title":"Br J Cancer"},{"key":"598_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e19541","volume":"9","author":"D Wekking","year":"2023","unstructured":"Wekking D, van Weelden WJ, Schoffelen C, Voortman J, Hendrikse NH, van Laarhoven HWM. Fibroblast growth factor receptors as targets for anticancer therapy in cholangiocarcinomas and urothelial carcinomas. Heliyon. 2023;9:e19541. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e19541.","journal-title":"Heliyon"},{"key":"598_CR72","doi-asserted-by":"publisher","first-page":"S196","DOI":"10.1038\/jid.1993.83","volume":"100","author":"I-M Shih","year":"1993","unstructured":"Shih I-M, Herlyn M. Role of growth factors and their receptors in the development and progression of melanoma. J Invest Dermatol. 1993;100:S196\u2013203. https:\/\/doi.org\/10.1038\/jid.1993.83.","journal-title":"J Invest Dermatol"},{"key":"598_CR73","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1038\/jid.2008.129","volume":"128","author":"JT Lee","year":"2008","unstructured":"Lee JT, Brafford P, Herlyn M. Unraveling the mysteries of IGF-1 signaling in melanoma. J Invest Dermatol. 2008;128:1358\u201360. https:\/\/doi.org\/10.1038\/jid.2008.129.","journal-title":"J Invest Dermatol"},{"key":"598_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1167\/iovs.01-0552","volume":"43","author":"C All-Ericsson","year":"2002","unstructured":"All-Ericsson C, Girnita L, Seregard S, Bartolazzi A, Jager MJ, Larsson O. Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target. Invest Ophthalmol Vis Sci. 2002;43:1\u20138. https:\/\/doi.org\/10.1167\/iovs.01-0552.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"598_CR75","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.gendis.2022.03.002","volume":"10","author":"P Wang","year":"2023","unstructured":"Wang P, Mak VCY, Cheung LWT. Drugging IGF-1R in cancer: new insights and emerging opportunities. Genes Dis. 2023;10:199\u2013211. https:\/\/doi.org\/10.1016\/j.gendis.2022.03.002.","journal-title":"Genes Dis"}],"container-title":["DARU Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-026-00598-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40199-026-00598-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-026-00598-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T16:02:11Z","timestamp":1780156931000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40199-026-00598-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["598"],"URL":"https:\/\/doi.org\/10.1007\/s40199-026-00598-x","relation":{},"ISSN":["2008-2231"],"issn-type":[{"value":"2008-2231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"27 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}